Abstract
Background
We measured the importance patients with gastrointestinal cancer and health care providers place on treatment outcomes, quality of life, and costs.
Methods
This cross-sectional survey study was conducted between June 1, 2020 and November 30, 2020. We identified surviving patients who had been treated or were anticipating treatment for pancreatic or gastric cancer at our single institution from January 1, 2000 through January 31, 2020. Surveys assessed the importance patients and providers placed on outcomes, well-being, costs, and experiences. Surveys measured how these values had changed over time. We compared the importance patients and providers place on each of the attributes of value.
Results
A total of 383 patients and 164 providers responded. Providers felt experience, emotional well-being, and costs were more important than patients themselves did (all p < 0.05). Patients more commonly reported that survival had become more important to them over time, while providers believed that emotional well-being, experience, and costs had become more important to patients (all p < 0.05). Postoperative patients ranked functional well-being as more important than preoperative patients did (p = 0.031). Patients of lower income and education levels more reported concerns of costs over the course of their care (both p < 0.05). Younger age was associated with concern for direct (r = −0.167, p = 0.004) and indirect costs (r = −0.318, p < 0.001).
Conclusions
Although there are consistencies amongst the views of cancer patients and providers, there remain discordances in the perception of value. Patients’ values differed across their treatment and survivorship course. These data demonstrate the importance of accounting for multistakeholder perspectives in assessments of value in health care.
Similar content being viewed by others
References
Porter ME, Lee TH. From volume to value in health care: the work begins. JAMA. 2016;316:1047–8.
Porter ME, Teisberg EO. Redefining health care: creating value-based competition on results. Boston: Harvard Business School Press; 2006.
Porter M, Lee T. The strategy that will fix health care. Harvard Business Review. October, 2013.
Schnipper LE, Davidson NE, Wollins DS, et al. Updating the American Society of Clinical Oncology Value Framework: revisions and reflections in response to comments received. J Clin Oncol. 2016;34:2925–34.
Available at https://www.nccn.org/guidelines/guidelines-with-evidence-blocks. Accessed 21 October 2021.
Aloia TA. Should zero harm be our goal? Ann Surg. 2020;271:33–6.
Allen CJ, Thaker NG, Prakash L, et al. Communicating value: use of a novel framework in the assessment of an enhanced recovery initiative. Ann Surg. 2021;273:e7-9.
Thaker NG, Ali TN, Porter ME, et al. Communicating value in health care using radar charts: a case study of prostate cancer. J Oncol Pract. 2016;12:813–20.
Kaplan RS, et al. Measuring and communicating health care value with charts. Harvard Business Review, October, 2015.
Balch A, Lakdawalla DN. The case for patient-centered assessment of value. Available at: https://www.healthaffairs.org/do/https://doi.org/10.1377/hblog20170508.059962/full. Accessed 19 October 2021.
Phelps CE, Madhavan G. Using multicriteria approaches to assess the value of health care. Value in Health. 2017;20:251–5.
Allen CJ, Eska JS, Thaker NG, et al. Developing a value framework: utilizing administrative data to assess an enhanced care initiative. J Surg Res. 2021;262:115–20.
de Souza JA, Seiwert TY. A value framework in head and neck cancer care. Am Soc Clin Oncol Educ Book. 2014;e304-9.
Garber AM, Phelps CE. Economic foundations of cost-effectiveness analysis. J Health Econ. 1997;16:1–31.
Marsh K, IJ M, Thokala P, et al. Multiple criteria decision analysis for health care decision making-emerging good practices: report 2 of the ISPOR MCDA emerging good practices task force. Value in Health. 2016;19:125–37.
Thokala P, Devlin N, Marsh K, et al. Multiple criteria decision analysis for health care decision making–an introduction: report 1 of the ISPOR MCDA emerging good practices task force. Value in Health. 2016;19:1–13.
Thaker NG, Pugh TJ, Mahmood U, et al. Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing. Brachytherapy. 2016;15:274–82.
Martin AJ, Glasziou PP, Simes RJ, et al. A comparison of standard gamble, time trade-off, and adjusted time trade-off scores. Int J Technol Assess Health Care. 2000;16:137–47.
American Cancer Society. Cancer Facts & Figures. 2017. Available at https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2017.html. Accessed 19 October 2021.
Katz MH, Wang H, Fleming JB, et al. Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol. 2009;16:836–47.
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.
Pecorelli N, Nobile S, Partelli S, et al. Enhanced recovery pathways in pancreatic surgery: state of the art. World J Gastroenterol. 2016;22:6456–68.
Available at: https://www.aapor.org/AAPOR_Main/media/TI-Updates-10-8.21/TI-Attachment-C.pdf. Accessed 19 December 2021.
Author information
Authors and Affiliations
Contributions
CJA is directly responsible for all aspects of this article. He participated in the concept, collection, analysis, and interpretation of data; drafting and revision of the manuscript. LP participated in the collection, analysis, and interpretation of data; drafting and revision of the manuscript. GLS, RJV, NI, TA, and VG participated as significant collaborators on concept, design, analysis, interpretation, and revision of the manuscript. They were critically important to the intellectual content. MHGK had overall responsibility for the study, including conception and design; analysis and interpretation; drafting and revision of the manuscript; obtaining funding for this project; supervision.
Corresponding author
Ethics declarations
Disclosure
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Allen, C.J., Smith, G.L., Prakash, L. et al. What is “Value”? Results of a Survey of Cancer Patients and Providers. Ann Surg Oncol 29, 6537–6545 (2022). https://doi.org/10.1245/s10434-022-11534-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-022-11534-z